A federal audit of Michigan’s Department of Corrections has slammed the state agency for overspending on medications.
The audit was particularly harsh in its review of the use of anti-psychotic medications, reports the Associated Press. The audit found that psychotropic medications accounted for $8 million in spending from January to July of 2010. That spending accounted for nearly 41 percent of all medication spending in the corrections system.
Auditors also took the state to task for its use of Seroquel, a name brand medication used to treat schizophrenia and bipolar disorder.
Seroquel, a treatment for schizophrenia and bipolar disorder, was the most prescribed antipsychotic drug. Auditors said the Corrections Department could have saved more than $350,000 a month by switching just half of the prescriptions to Risperdal, a cheaper drug that is off patent and has generic rivals.
Russ Marlan, a spokesman for MDOC, says the state concurred with many of the auditor’s concerns and has since taken action to remedy concerns, including reducing the use of Seroquel, and opting or Risperdal. The report is particularly striking in that the department overspent its budget allocations by $46 million last fiscal year.